News

Nicola Magrini: "The AIFA reform is a mistake"

AIFA less independent. "After all, it seems to me that the reform has received the approval of the pharmaceutical industry"

The AIFA General Director, Nicola Magrini, In una interview with the press today comments on the recent reform of the Agency approved by the Parliament

Prof. Negrini recounts that immediately after New Year's Eve, he received a letter from Minister Orario Schillaci, who metaphorically kicked him out: spoils system. According to the DG, the spoils system rule should not apply in a technical agency such as AIFA. The risk is to create scientific and organizational discontinuity. In fact, the other European agencies are not subject to the spoils system.

Prof. Negrini does not think that his removal is due to AIFA's attitude towards the Covid pandemic. Remember that more than 200 studies on Covid carried out in Italy have been examined, of which only a third have been approved.

Dr. Magrini then criticizes the method by which this reform was arrived at: "such an important reform, on such a complex matter, cannot be done with an amendment inserted into a decree law".

I fear, continues Magrini, that there is a desire to return to the regulatory perimeter only with the sole aim of getting drugs approved more quickly, without an overall health assessment. There is a risk of losing awareness that there are medicines that are more important and innovative than others to which access must be guaranteed timely throughout the country.

Furthermore, Dr. Magrini fears that the "new" AIFA will be less capable of independently resisting market pressures. "After all, it seems to me that the reform has received the approval of the pharmaceutical industry"

Continuing Dr. Magrini, he hopes for greater integration between the State and the Regions and a strengthening of personnel. I fear, concludes Dr. Magrini, that a stronger AIFA would have frightened many.

 

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco